Scale innovation.


lenacapavir – a six-monthly injection to prevent HIV, remind us that progress continues.


The fight against HIV has never been easy, yet resilience and innovation continue to define the response.

As global funding falters, advances like long-acting lenacapavir – a six-monthly injection to prevent HIV, remind us that progress continues. With commitment and creativity, we can ensure that lifesaving long acting antiretrovirals for prevention and treatment reach those in most need
Location: Africa

Comments

Post a Comment

Popular posts from this blog

Empower communities.

Image
Communities are the driving force of the HIV response . People living with HIV and those most affected, including key populations bring the insight, courage, and innovation needed to overcome today’s challenges. When these communities join forces with health workers, policymakers, and partners, new pathways to success emerge, built on trust, equity and shared purpose .
Read more

Global AIDS Strategy 2026-2031.

Image
  United Towards ending AIDS. * Countries in the Middle East and North Africa were engaged through UNAIDS offices in eastern and southern Africa and in western and central Africa.  ** Approximately 93 country governments and 360 civil society organizations were consulted during this period. Consultations continued subsequently.
Read more